The lymph node metastases analysis showed an association of KRAS mutation with N2, considering that 30 tumours with KRAS mutation (55.6%) were included in this category, while 4 mCRCs were not associated with KRAS mutation. The gene discussed is KRAS; the disease is neoplasm.